Literature DB >> 28891182

Rare disease registries: a call to action.

Paul Lacaze1, Nicole Millis2, Megan Fookes2, Yvonne Zurynski3,4, Adam Jaffe5,6, Matthew Bellgard7, Ingrid Winship8,9, John McNeil1, Alan H Bittles7,10.   

Abstract

When registries collect accurate clinical data over time, they can act as fundamental support structures for patients and their families and powerful cost-effective instruments to support clinical trials and translational research to improve quality of care, quality of life and survival. Registries are critical for rare diseases (RD) with low prevalence and propensity for variation in treatment and outcomes. Rare Voices Australia is leading a call for action to the research and clinical community to prioritise RD data collection and develop an integrated RD Registry strategy for Australia. Financial, operational and governance challenges exist for establishing and maintaining RD registries. As a multidisciplinary team whose interests converge on RD, we highlight the need for the establishment of an Australian RD Registry Alliance. This 'umbrella' organisation will: (i) bring together existing RD registries across Australia; (ii) establish National RD Registry Standards to support interoperability and cohesion across registries; (iii) develop strategies to attract sustainable funding from government and other sources to maximise the utility of existing RD registries and support the development of new RD registries. The most important role for the Alliance would be to use the RD registries for translational research to address current knowledge gaps about RD and to improve the care for the over 1.4 million Australians estimated to live with RD.
© 2017 Royal Australasian College of Physicians.

Entities:  

Keywords:  clinical registries; genetics; rare disease; registries

Mesh:

Year:  2017        PMID: 28891182     DOI: 10.1111/imj.13528

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  8 in total

1.  Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.

Authors:  James A Feinstein; Purevsuren Jambal; Kathleen Peoples; Anne W Lucky; Phuong Khuu; Jean Y Tang; Irene Lara-Corrales; Elena Pope; Karen Wiss; Kristen P Hook; Laura E Levin; Kimberly D Morel; Amy S Paller; Catherine C McCuaig; Julie Powell; Lawrence F Eichenfield; Harper Price; Moise L Levy; Lawrence A Schachner; John C Browning; Susan Bayliss; Marla Jahnke; Tor Shwayder; Sharon A Glick; Anna L Bruckner
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

Review 2.  The involvement of rare disease patient organisations in therapeutic innovation across rare paediatric neurological conditions: a narrative review.

Authors:  Christina Q Nguyen; Kristine Alba-Concepcion; Elizabeth E Palmer; Jackie L Scully; Nicole Millis; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2022-04-18       Impact factor: 4.303

3.  RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework.

Authors:  Matthew I Bellgard; Tom Snelling; James M McGree
Journal:  Orphanet J Rare Dis       Date:  2019-07-12       Impact factor: 4.123

4.  Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.

Authors:  Lei Zhang; Yining Bao; Moeen Riaz; Jane Tiller; Danny Liew; Xun Zhuang; David J Amor; Aamira Huq; Lara Petelin; Mark Nelson; Paul A James; Ingrid Winship; John J McNeil; Paul Lacaze
Journal:  Genet Med       Date:  2019-02-18       Impact factor: 8.822

5.  Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry.

Authors:  Sophia Z Shalhout; Farees Saqlain; Kayla Wright; Oladayo Akinyemi; David M Miller
Journal:  JAMIA Open       Date:  2022-01-07

6.  Rare single gene disorders: estimating baseline prevalence and outcomes worldwide.

Authors:  Hannah Blencowe; Sowmiya Moorthie; Mary Petrou; Hanan Hamamy; Sue Povey; Alan Bittles; Stephen Gibbons; Matthew Darlison; Bernadette Modell
Journal:  J Community Genet       Date:  2018-08-14

7.  Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Authors:  Libby Wood; Guillaume Bassez; Corinne Bleyenheuft; Craig Campbell; Louise Cossette; Aura Cecilia Jimenez-Moreno; Yi Dai; Hugh Dawkins; Jorge Alberto Diaz Manera; Celine Dogan; Rasha El Sherif; Barbara Fossati; Caroline Graham; James Hilbert; Kristinia Kastreva; En Kimura; Lawrence Korngut; Anna Kostera-Pruszczyk; Christopher Lindberg; Bjorn Lindvall; Elizabeth Luebbe; Anna Lusakowska; Radim Mazanec; Giovani Meola; Liannna Orlando; Masanori P Takahashi; Stojan Peric; Jack Puymirat; Vidosava Rakocevic-Stojanovic; Miriam Rodrigues; Richard Roxburgh; Benedikt Schoser; Sonia Segovia; Andriy Shatillo; Simone Thiele; Ivailo Tournev; Baziel van Engelen; Stanislav Vohanka; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2018-09-05       Impact factor: 4.123

8.  Standardised clinical data from patients with primary ciliary dyskinesia: FOLLOW-PCD.

Authors:  Myrofora Goutaki; Jean-François Papon; Mieke Boon; Carmen Casaulta; Ernst Eber; Estelle Escudier; Florian S Halbeisen; Amanda Harris; Claire Hogg; Isabelle Honore; Andreas Jung; Bulent Karadag; Cordula Koerner-Rettberg; Marie Legendre; Bernard Maitre; Kim G Nielsen; Bruna Rubbo; Nisreen Rumman; Lynne Schofield; Amelia Shoemark; Guillaume Thouvenin; Hannah Willkins; Jane S Lucas; Claudia E Kuehni
Journal:  ERJ Open Res       Date:  2020-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.